Use of interval-censored survival data as an alternative to Kaplan-Meier survival curves: studies of oral lesion occurrence in liver transplants and cancer recurrence
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rubin S, Randall T, Armstrong K, Chi D, Hoskins W. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol. 1999; 93:21.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53:457–81.
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50:163–70.
Cox DR. Regression models and life-tables. J R Stat Soc B. 1972; 34:187–220.
Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008; 26:1275–81.
Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol. 2010; 11:121–8.
da Costa AA, Valadares CV, Baiocchi G, Mantoan H, Saito A, Sanches S, Guimarães AP, Achatz MIW. Neoadjuvant chemotherapy followed by interval debulking surgery and the risk of platinum resistance in epithelial ovarian cancer. Ann Surg Oncol. 2015; 22:971–8.
Del Carmen M, Supko J, Horick N, et al.Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer. Cancer. 2016; 122(21).
Bahnassy AA, El-Sayed M, Ali NM, Khorshid O, Hussein MM, Yousef HF, Mohanad MA, Zekri A-RN, Salem SE. Aberrant expression of miRNAs predicts recurrence and survival in stage-II colorectal cancer patients from Egypt. Appl Cancer Res. 2017; 37(39):1–13.
Rücker G, Messerer D. Remission duration: an example of interval-censored observations. Stat Med. 1988; 7:1139–45.
Law CG, Brookmeyer R. Effects of mid-point imputation on the analysis of doubly censored data. Stat Med. 1992; 11:1569–78.
Odell PM, Anderson KM, D’Agostino RB. Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics. 1992; 48:951–9.
Turnbull BW. Nonparametric estimation of a survivorship function with doubly censored data. J Am Stat Assoc. 1974; 69:169–73.
Turnbull BW. The empirical distribution function with arbitrarily grouped, censored and truncated data. J R Stat Soc. 1976; 38:290–5.
Finkelstein DM, Wolfe RA. A semiparametric model for regression analysis of interval-censored failure time data. Biometrics. 1985; 41:933–45. s
Finkelstein DM. A proportional hazards model for interval-censored failure time data. Biometrics. 1986; 42:845–54.
Goetghebeur E, Ryan L. Semiparametric regression analysis of interval-censored data. Biometrics. 2000; 56:1139–44.
Betensky RA, Rabinowitz D, Tsiatis AA. Computationally simple accelerated failure time regression for interval censored data. Biometrika. 2001; 88:703–11.
Lesaffre E, Komárek A, Declerck D. An overview of methods for interval-censored data with an emphasis on applications in dentistry. Stat Methods Med Res. 2005; 14:539–52.
Zhang M, Davidian M. “Smooth” semiparametric regression analysis for arbitrarily censored time-to-event data. Biometrics. 2008; 64:567–76.
Sparling YH, Younes N, Lachin JM, Bautista OM. Parametric survival models for interval-censored data with time-dependent covariates. Biostatistics. 2006; 7:599–614.
Lindsey JC, Ryan LM. Tutorial in biostistics: Methods for interval-censored data. Stat Med. 1998; 17:219–38.
Achcar JA, Tomazella VLD, Saito MY. Lifetime interval-censored data: a Bayesian approach. J Appl Stat Sci. 2007; 16:77–89.
Gómez G, Calle ML, Oller R, Langohr K. Tutorial on methods for interval-censored data and their implementation in R. Stat Model. 2009; 9:259–97.
Rodrigues AS, Bhering FL, Pereira CAB, Polpo A. Bayesian estimation of component reliability in coherent systems. IEEE Access. 2018; 6:18520–35.
Wienke A. Frailty Models in Survival Analysis. Boca Raton: Chapman & Hall/CRC; 2011.
Goel M, Khanna P, Kishore J. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010; 1:274–8.
Maller RA, Zhou X. Survival Analysis with Long-term Survivors. New York: Wiley; 1996.
Rich JT, Neely JG, Paniello RC, Voelker CC, Nussenbaum B, Wang EW. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg. 2010; 143:331–6.
Klein JP, Moeschberger ML. Survival analysis: Statistical methods for censored and truncated data. 2003.
R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2018. R Foundation for Statistical Computing. https://www.R-project.org/ .
Therneau TM. A Package for Survival Analysis in S. 2015. version 2.38. https://CRAN.R-project.org/package=survival .
Gentleman R, Vandal A. Icens: NPMLE for Censored and Truncated Data. 2018. R package version 1.52.0.
StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC. 2017.
SAS Institute Inc. Cary NC USA. 2014.